From Clinical Miracle to Public Health Priority: A Comprehensive Analysis of the Cost and Accessibility Dynamics in India's CAR T-Cell Therapy Market
  The emergence of CAR T-cell therapy represents one of the most significant revolutions in oncology, particularly for the treatment of hematological malignancies, and its trajectory in the Indian subcontinent is a tale of immense scientific potential struggling against massive accessibility challenges. India, with its substantial burden of blood cancers, including aggressive B-cell...
0 Kommentare 0 Geteilt 14 Ansichten 0 Bewertungen